Antibiotics and breast-feeding: A critical review of the literature

Pediatric Drugs

Volumn 4, Issue 12, 2002, Pages 817-837

  Chung, Allison M ^a,b   Reed, Michael D ^a,b   Blumer, Jeffrey L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DICLOXACILLIN; ERYTHROMYCIN; GENTAMICIN; LATAMOXEF; MACROLIDE; METRONIDAZOLE; NITROFURANTOIN; OFLOXACIN; PEFLOXACIN; PENICILLIN G; PENICILLIN V; PIVAMPICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAFURAZOLE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG; VANCOMYCIN;

APLASTIC ANEMIA; ARTHROPATHY; BONE DEFECT; BONE EROSION; BONE MARROW SUPPRESSION; BREAST FEEDING; BREAST MILK; DIARRHEA; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CARCINOGENICITY; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG MILK LEVEL; DRUG TOLERABILITY; GASTRITIS; GASTROINTESTINAL SYMPTOM; HEMOLYTIC ANEMIA; HUMAN; INFANT; INTESTINE FUNCTION DISORDER; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; PUERPERIUM; PYLORUS STENOSIS; REVIEW; RISK ASSESSMENT; TOOTH MALFORMATION; VOMITING;

EID: 0036907213     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200204120-00006     Document Type: Review

References (134)

1. Powers NG, Slusser W. Breast-feeding update (2): Clinical lactation management. Pediatr Rev 1997; 18: 147-61
2. Freed G. Breast feeding: Time to teach what we preach. JAMA 1993; 269: 243-5
3. Ryan A. The resurgence of breast-feeding in the United States. Pediatrics 1997; 99: E12
4. Promotion of breast feeding: Recommendations of the Councils of the Society for Pediatric Research (SPR) and American Pediatric Society (APS), and of the American Academy of Pediatrics (AAP). Pediatr Res 1982; 16: 264-5
5. American Academy of Pediatrics, Breast-feeding Workgroup. Breast-feeding and the use of human milk. Pediatrics 1997; 100: 1035-9
6. Kramer MS, Chalmers B, Hodnett ED, et al. Promotion of breast-feeding intervention trial (PROBIT): A randomized trial in the Republic of Belarus. JAMA 2001; 285: 413-20
7. World Health Organization. Global strategy for infant and young child feeding: The optimal duration of exclusive breast-feeding. 54th World Health Assembly, Geneva, Switzerland [online]. Available from URL: http://www.who.int/gb/EB_WHA/PDF/WHA54/ea54id4.pdf [Accessed 2002 Jun 10]
8. Kelleher DK, Duggan C. Breast milk and breast-feeding in the 1990s. Curt Opin Pediatr 1999; 11: 275-80
9. Vandenplas Y. Myths and facts about breast-feeding: Does it prevent later atopic disease. Obstet Gynecol Surv 1998; 53: 536-7
10. Lawrence R, Lawrence R. Breast-feeding: A Guide for the Medical Profession. St Louis (MO): Mosby Inc. 1999
11. Department of Health and Human Services, Public Health Service. Healthy People 2000 Progress Review: Maternal and Infant Health [online]. Available from URL: http://odphp.osophs.dhhs.gov/pubs/hp2000/PDF/prog_rvw/matinf99.pdf [Accessed 2002 Aug 19]
12. Lawrence RA. Breast-feeding and medical disease. Med Clin North Am 1989; 73: 583-603
13. Evans M. Heads J. Mastitis: Incidence, prevalence and cost results of a twelvemonth survey of three Sydney Area Health Services. Breastfed Rev 1995; 3: 65-72
14. Ito S, Koren G, Einarson TR. Maternal noncompliance with antibiotics during breast-feeding. Ann Pharmacother 1993; 27: 40-2
15. Matheson I, Kristensen K, Lunde PK. Drug utilization in breast feeding women: A survey in Oslo. Eur J Clin Pharmacol 1990; 38: 453-9
16. Anderson PO. Drug use during breast-feeding. Clin Pharm 1991; 10: 594-624
17. Schneider S, McBride K. Physician attitudes and practices in febrile breast-feeding mothers [poster]. Pediatr Res 1996; 39: 140
18. Catz C, Giacoia G. Drugs and breast milk. Pediatr Clin North Am 1972; 19: 151-66
19. Wilson JT. Determinants and consequences of drug excretion in breast milk. Drug Metab Rev 1983; 14: 619-52
20. Hardman J, Limbird L. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw Hill, 1996
21. Wilson JT, Brown RD, Cherek DR, et al. Drug excretion in human breast milk: Principles, pharmacokinetics and projected consequences. Clin Pharmacokinet 1980; 5: 1-66
22. Begg EJ, Atkinson HC, Duffull SB. Prospective evaluation of a model for the prediction of milk: pLasma drug concentrations from physicochemical characteristics. Br J Clin Pharmacol 1992; 33: 501-5
23. Kremer JM, Wilting J, Janssen LH. Drug binding to human alpha-1-acid glyco-protein in health and disease. Pharmacol Rev 1988; 40: 1-47
24. McElnay JC, D'Arcy PF. Protein binding displacement interactions and their clinical importance. Drugs 1983; 25: 495-513
25. Dean M, Stock B, Patterson RJ, et al. Serum protein binding of drugs during and after pregnancy in humans. Clin Pharmacol Ther 1980; 28: 253-61
26. Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 1997; 33: 328-43
27. Atkinson HC, Begg EJ. The binding of drugs to major human milk whey proteins. Br J Clin Pharmacol 1988; 26: 107-9
28. Stebler T. Guentert TW. Binding of drugs in milk: The role of casein in milk protein binding. Pharm Res 1990; 7: 633-7
29. Ito S, Koren G. A novel index for expressing exposure of the infant to drugs in breast milk. Br J Clin Pharmacol 1994; 38: 99-102
30. Pons G, Rey E, Matheson I. Excretion of psychoactive drugs into breast milk: Pharmacokinetic principles and recommendations. Clin Pharmacokinet 1994; 27: 270-89
31. Wilson JT, Brown RD, Hinson JL, et al. Pharmacokinetic pitfalls in the estimation of the breast milk/plasma ratio for drugs. Annu Rev Pharmacol Toxicol 1985; 25: 667-89
32. Ito S. Drug therapy for breast feeding women. N Engl J Med 2000; 343: 118-26
33. Atkinson HC, Begg EJ. Prediction of drug distribution into human milk from physicochemical characteristics. Clin Pharmacokinet 1990; 18: 151-67
34. Fleiss PM, Richwald GA, Gordon J. et al. Aztreonam in human serum and breast milk. Br J Clin Pharmacol 1985; 19: 509-11
35. Atkinson HC, Begg EJ. Prediction of' drug concentrations in human skim milk from plasma protein binding and acid-base characteristics. Br J Clin Pharmacol 1988; 25: 495-503
36. Atkinson HC, Begg EJ. Relationship between human milk lipid-ultrafiltrate and octanol-water partition coefficients. J Pharm Sci 1988; 77: 796-8
37. Agatonovic-Kustrin S. Tucker IG, Zecevic M, et al. Prediction of drug transfer into human milk from theoretically derived descriptors. Anal Chim Acta 2000; 418: 181-95
38. Greene HJ, Burkhart B, Hobby GL. Excretion of penicillin in human milk following parturition. Am J Obstet Gynecol 1946; 51: 732-3
39. Campbell AC, McElnay JC, Passmore CM. The excretion of ampicillin in breast milk and its effects on the suckling infant [abstract]. Br J Clin Pharmacol 1991; 31: 230P
40. Blanco JD, Jorgensen JH, Castaneda YS, et al. Ceftazidime levels in human breast milk. Antimicrob Agents Chemother 1983; 23: 479-80
41. Miller RD, Keegan KA, Thrupp LD, et al. Human breast milk concentration of moxalactam. Am J Obstet Gynecol 1984; 148; 348-9
42. Giamarellou H, Kolokythas E, Petrikkos G, et al. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med 1989; 87: 49-51S
43. Kauffman RE, O'Brien C. Gilford P. Sulfisoxazole secretion into human milk. J Pediatr 1980; 97: 839-41
44. Miller RD, Salter AJ. The passage of trimethoprim/sulphamethoxazole into breast milk and its significance: Progress in chemotherapy (antibacterial, antiviral, antineoplastic). Proc Int Cong Chemother 1974; 1: 687-91
45. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Baltimore (MD): Williams & Wilkins, 1998
46. Kelsey JJ, Moser LR, Jennings JC, et al. Presence of azithromycin breast milk concentrations: A case report. Am J Obstet Gynecol 1994; 170: 1375-6
47. Celiloglu M, Celiker S, Guven H, et al. Gentamicin excretion and uptake from breast milk by nursing infants. Obstet Gynecol 1994; 84: 263-5
48. Tetracycline in breast milk [letter]. BMJ 1969; 4: 791
49. Pons G, Rey E, Richard MO, et al. Nitrofurantoin excretion in human milk. Dev Pharmacol Ther 1990; 14: 148-52
50. Erickson SH, Oppenheim GL, Smith GH. Metronidazole in breast milk. Obstet Gynecol 1981; 57: 48-50
51. Passmore CM, McElnay JC, Rainey EA, et al. Metronidazole excretion in human milk and its effect on the suckling neonate. Br J Clin Pharmacol 1988; 26: 45-51
52. Reyes MP, Ostrea Jr EM, Cabinian AE, et al. Vancomycin during pregnancy: Does it cause hearing loss or nephrotoxicity in the infant. Am J Obstet Gynecol 1989; 161: 977-81
53. Smith JA, Morgan JR, Rachlis AR, et al. Clindamycin in human breast milk [letter]. Can Med Assoc J 1975; 112: 806
54. Steen B, Rane A. Clindamycin passage into human milk. Br J Clin Pharmacol 1982; 13: 661-4
55. Havelka J, Frankova A. Adverse effects of chloramphenicol in newborn infants. Cesk Pediatr 1972; 27: 31-3
56. Reed MD, Besunder JB. Developmental pharmacology: Ontogenic basis of drug disposition. Pediatr Clin North Am 1989; 36: 1053-74
57. Kearns GL, Reed MD. Clinical pharmacokinetics in infants and children: A reappraisal. Clin Pharmacokinet 1989; 17: 29-67
58. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995; 273: 214-9
59. Thomas M, Jairaj P, Mathew LG. A prospective study in a southern Indian hospital on the prescription of medication during the lying-in period following childbirth. Soz Praventiv Med 1994; 39: 273-9
60. Ito S, Blajchman A, Stephenson M, et al. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 1993; 168: 1393-9
61. Larimore WL, Petrie KA. Drug use during pregnancy and lactation. Prim Care 2000; 27: 35-53
62. Vogel A, Hutchison BL, Mitchell EA. Mastitis in the first year postpartum. Birth 1999; 26: 218-25
63. Olsen CG, Gordon JR RE. Breast disorders in nursing mothers. Am Fam Physician 1990; 41: 1509-16
64. Edwards MS. Antibacterial therapy in pregnancy and neonates. Clin Perinatol 1997; 24: 251-66
65. Nathwani D, Wood MJ. Penicillins: A current review of their clinical pharmacology and therapeutic use. Drugs 1993; 45: 866-94
66. Clark RA. Infections during the postpartum period. J Obstet Gynecol Neonatal Nurs 1995; 24: 542-8
67. Livingstone V, Stringer LJ. The treatment of Staphyloccocus aureus infected sore nipples: A randomized comparative study. J Hum Lact 1999; 15: 241-6
68. Jonsson S, Pulkkinen MO. Mastitis today: Incidence, prevention and treatment. Ann Chir Gynaecol Suppl 1994; 208: 84-7
69. Gentry LO. Cephalosporins in urinary tract infection. Drugs 1987; 34: 154-63
70. Kafetzis DA, Brater DC, Fanourgakis JE, et al. Ceftriaxone distribution between maternal blood and fetal blood and tissues at parturition and between blood and milk postpartum. Antimicrob Agents Chemother 1983; 23: 870-3
71. Kafetzis DA, Lazarides CV, Siafas CA, et al. Transfer of cefotaxime in human milk and from mother to foetus. J Antimicrob Chemother 1980; 6 Suppl. A: 135-41
72. Kafetzis DA, Siafas CA, Georgakopoulos PA, et al. Passage of cephalosporins and amoxicillin into the breast milk. Acta Paediatr Scand 1981; 70: 285-8
73. Dresse A, Lambotte R, Dubois M, et al. Transmammary passage of cefoxitin: Additional results. J Clin Pharmacol 1983; 23: 438-40
74. Branebjerg PE, Heisterberg L. Blood and milk concentrations of ampicillin in mothers treated with pivampicillin and in their infants. J Perinat Med 1987; 15: 555-8
75. Roex AJ, van Loenen AC, Puyenbroek JI, et al. Secretion of cefoxitin in breast milk following short-term prophylactic administration in caesarean section. Eur J Obstet Gynecol Reprod Biol 1987; 25: 299-302
76. Yoshioka H, Cho K, Takimoto M, et al. Transfer of cefazolin into human milk. J Pediatr 1979; 94: 151-2
77. Fulton B, Moore L. Anti-infectives in breast-milk (Part I): Penicillins and cephalosporins. J Hum Lact 1992; 8: 157-8
78. Matsuda S. Transfer of antibiotics into maternal milk. Biol Res Pregnancy Perinatol 1984; 5: 57-60
79. Bourget P, Quinquis-Desmaris V. Fernandez H. Ceftriaxone distribution and protein binding between maternal blood and milk postpartum. Ann Pharmacother 1993; 27: 294-7
80. Dubois M, Delapierre D, Chanteux L, et al. A study of the transplacental transfer and the mammary excretion of cefoxitin in humans. J Clin Pharmacol 1981; 21: 477-83
81. Shyu WC, Shah VR, Campbell DA, et al. Excretion of cefprozil into human breast milk. Antimicrob Agents Chemother 1992; 36: 938-41
82. Blumer J. Pharmacokinetics of ceftriaxone. Hosp Pract (Off Ed) 1991; 26 Suppl. 5: 7-13; discussion 52-4
83. Murray L, Seger D. Drug therapy during pregnancy and lactation. Emerg Med Clin North Am 1994; 12: 129-49
84. Chow AW, Jewesson PJ. Pharmacokinetics and safety of antimicrobial agents during pregnancy. Rev Infect Dis 1985; 7: 287-313
85. American Academy of Pediatrics, Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 1989; 84: 924-36
86. American Academy of Pediatrics, Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 1994; 93: 137-50
87. Data on File, Merck Human Health Division, 2001
88. McEvoy GK. AHFS Drug Information 2000. Bethesda (MD): American Society of Health System Pharmacists, 2000
89. O'Donnell JA, Gelone SP. Fluoroquinolones. Infect Dis Clin North Am 2000; 14: 489-513
90. Gardner DK, Gabbe SG, Harter C. Simultaneous concentrations of ciprofloxacin in breast milk and in serum in mother and breast-fed infant. Clin Pharm 1992; 11: 352-4
91. Cover DL, Mueller BA. Ciprofloxacin penetration into human breast milk: A case report. DICP 1990; 24: 703-4
92. Harmon T, Burkhart G, Applebaum H. Perforated pseudomembranous colitis in the breast-fed infant. J Pediatr Surg 1992; 27: 744-6
93. Fulton B, Moore LL. Anti-infectives in breast-milk (Part III): Antituberculars, quinolones and urinary germicides. J Hum Lact 1993; 9: 43-6
94. Stoukides CA. Quinolone antibiotics and breast-feeding. J Hum Lact 1991; 7: 143-4
95. Murray L, editor. Physicians' Desk Reference. 55th Ed. Montvale (NJ): Medical Economics Company, Inc., 2001
96. Gough A, Barsoum NJ, Mitchell L, et al. Juvenile canine drug-induced arthropathy: Clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids. Toxicol Appl Pharmacol 1979; 51: 177-87
97. Burkhardt JE, Hill MA, Turek JJ, et al. Ultrastructural changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Vet Pathol 1992; 29: 230-8
98. Burkhardt JE, Hill MA, Carlton WW. Morphologic and biochemical changes in articular cartilages of immature beagle dogs dosed with difloxacin. Toxicol Pathol 1992; 20: 246-52
99. Chevalier X, Albengres E, Voisin MC, et al. A case of destructive polyarthropathy in a 17-year-old youth following pefloxacin treatment. Drug Saf 1992; 7: 310-4
100. Dixey J, Redington AN, Butler RC, et al. The arthropathy of cystic fibrosis. Ann Rheum Dis 1988; 47: 218-23
101. Alfaham M, Holt ME, Goodchild MC. Arthropathy in a patient with cystic fibrosis taking ciprofloxacin [letter]. BMJ (Clin Res Ed) 1987; 295: 699
102. Lien EJ, Kuwahara J, Koda RT. Diffusion of drugs into prostatic fluid and milk. Drug Intel Clin Pharm 1974; 8: 470-6
103. Stewart HL, Pratt JP. Sulfanilamide excretion in human breast milk and effect on breast-fed babies. JAMA 1938; 111: 1456-8
104. Reed MD, Besunder JB, Blumer JL. Sulfonamides. In: Koren G, Prober CG, Gold R, editors. Antimicrobial Therapy in Infants and Children. New York: Marcel Dekker Inc., 1988; 153-72
105. Dillon AE, Wagner CL, Wiest D, et al. Drug therapy in the nursing mother. Obstet Gynecol Clin North Am 1997; 24: 675-96
106. Odell GB. Studies in kernicterus (I): The protein binding of bilirubin. J Clin Invest 1959; 38: 823-33
107. Atkinson HC, Begg EJ, Darlow BA. Drugs in human milk: Clinical pharmacokinetic considerations. Clin Pharmacokinet 1988; 14: 217-40
108. Peters DH, Friedel HA, McTavish D. Azithromycin: a review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 1992; 44: 750-99
109. Zhang Y, Zhang Q, Xu Z. Tissue and body fluid distribution of antibacterial agents in pregnant and lactating women. Chung Hua Fu Chan Ko Tsa Chih 1997; 32: 288-92
110. Sedlmayr T, Peters F, Raasch W, et al. Clarithromycin, a new macrolide antibiotic: Effectiveness in puerperal infections and pharmacokinetics in breast milk [in German]. Geburtshilfe Frauenheilkd 1993; 53: 488-91
111. Stang H. Pyloric stenosis associated with erythromycin ingested through breast-milk. Minn Med 1986; 69: 669-70
112. Brogden RN, Pinder RM, Sawyer PR, et al. Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use. Drugs 1976; 12: 166-200
113. Mann CF. Clindamycin and breast-feeding. Pediatrics 1980; 66: 1030-1
114. Gennaro A. Remington's pharmaceutical sciences. Eaton: Mack Publishing Company, 1990
115. Saivin S, Houin G. Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet 1988; 15: 355-66
116. Morganti G, Ceccarelli G, Ciaffi G. Comparative concentrations of a tetracycline antibiotic in serum and maternal milk. Antibiotica 1968; 6: 216-23
117. Brogden RN, Speight TM, Avery GS. Minocycline: a review of its antibacterial and pharmacokinetic properties and therapeutic use. Drugs 1975; 9: 251-91
118. Posner AC, Prigot A, Konicoff NG. Further observations on the use of tetracycline hydrochloride in prophylaxis and treatment of obstetric infections. Antibiot Ann 1954; 54: 594-8
119. Stewart DJ. Prevalence of tetracyclines in children's teeth (II): A resurvey after five years. BMJ 1973; 3: 320-2
120. Grossman ER, Walchek A, Freedman H. Tetracyclines and permanent teeth: The relation between dose and tooth color. Pediatrics 1971; 47: 567-70
121. Bennett IC, Proffit WR, Norton LA. Determination of growth inhibitory concentrations of tetracycline for bone in organ culture. Nature 1967; 216: 176-7
122. Varsano I, Fischl J, Shochet SB. The excretion of orally ingested nitrofurantoin in human milk. J Pediatr 1973; 82: 886-7
123. Heisterberg L, Branebjerg PE. Blood and milk concentrations of metronidazole in mothers and infants. J Perinat Med 1983; 11: 114-20
124. Beard CM, Noller KL, O'Fallon WM, et al. Lack of evidence for cancer due to use of metronidazole. N Engl J Med 1979; 301: 519-22
125. Rustia M, Shubik P. Induction of lung tumors and malignant lymphomas in mice by metronidazole. J Natl Cancer Inst 1972; 48: 721-9
126. Legator MS, Connor T, Stoeckel M. The detection of mutagenic substances in the urine and blood of man. Ann NY Acad Sci 1975; 269: 16-20
127. Legator MS, Connor TH, Stoeckel M. Detection of mutagenic activity of metronidazole and niridazole in body fluids of humans and mice. Science 1975; 188: 1118-9
128. Einarson A, Ho E, Koren G. Can we use metronidazole during pregnancy and breast-feeding: Putting an end to the controversy. Can Fam Physician 2000; 46: 1053-4
129. Lucas RA, Bowtle WJ, Ryden R. Disposition of vancomycin in healthy volunteers from oral solution and semi-solid matrix capsules. J Clin Pharm Ther 1987; 12: 27-31
130. Rodvold KA, Everett JA, Pryka RD, et al. Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children. Clin Pharmacokinet 1997; 33: 32-51
131. Scott JI, Finegold SM, Belkin GA, et al. A controlled double-blind study of the hematologic toxicity of chloramphenicol. N Engl J Med 1965; 272: 1137-42
132. Yunis AA, Smith US, Restrepo A. Reversible bone marrow suppression from chloramphenicol: A consequence of mitochondrial injury. Arch Intern Med 1970; 126: 272-5
133. Sutherland JM. Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. Am J Dis Child 1959; 97: 761-7
134. Weiss CF, Glazko AJ, Weston JK. Chloramphenicol in the newborn infant: A physiologic explanation of its toxicity when given in excessive doses. N Engl J Med 1960; 262: 787-94